Search results for "Highlights"


 
Results 121 - 130 of about 387 for "Highlights".
Sort by: Relevance | Newest | Oldest

Diabetes patients with healthy lifestyles appear to have low, no excess CVD risk, study finds

An accompanying editorial called for broader international efforts to target cardiovascular risk through programs that encourage healthy lifestyles.
https://diabetes.acponline.org/archives/2019/08/09/2.htm
9 Aug 2019

Different diabetes phenotypes associated with varying prevalence of complications

Patients were categorized into five groups: mild age-related diabetes, mild obesity-related diabetes, severe autoimmune diabetes, severe insulin-resistant diabetes, and severe insulin-deficient diabetes.
https://diabetes.acponline.org/archives/2019/08/09/3.htm
9 Aug 2019

Weight loss through gastric bypass or diet improved insulin sensitivity in patients with type 2 diabetes

Results from this small study suggest that reducing adipose tissue volume, by whatever means, will improve blood glucose control in patients with type 2 diabetes, an accompanying editorial noted.
https://diabetes.acponline.org/archives/2020/09/11/1.htm
11 Sep 2020

Young adults with diabetes have less favorable cardiometabolic risk profile versus those without, study finds

Compared to young adults without diabetes, those with diabetes were more likely to have obesity, elevated lipids, or hypertension and were less likely to report being physically active or consuming a healthy diet.
https://diabetes.acponline.org/archives/2019/07/12/2.htm
12 Jul 2019

Patient-centered diabetes care varies in intensity by both disease- and patient-related factors

Patients were more likely to choose more intensive care after an annual consultation if they had a high level of education, if they were concerned about illness, if they had set goals for their care, and if they had comorbid conditions.
https://diabetes.acponline.org/archives/2019/07/12/3.htm
12 Jul 2019

Cardiology guidance supports use of SGLT-2 inhibitors, GLP-1 receptor agonists for CV benefits in diabetes

Evidence on sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists indicates that these drugs can be used not just for glucose control but for cardiovascular (CV) risk reduction in patients with type 2 diabetes, according to a new expert pathway.
https://diabetes.acponline.org/archives/2020/08/14/1.htm
14 Aug 2020

AHA offers new guidance on treating diabetes and heart failure

A scientific statement from the American Heart Association and the Heart Failure Society of America describes new approaches to medications, lifestyles, and the importance of multidisciplinary care that includes physicians and other clinicians.
https://diabetes.acponline.org/archives/2019/06/14/3.htm
14 Jun 2019

ADA updates standards of care related to CV, renal health in type 2 diabetes

The updates were based on findings from the industry-funded CREDENCE (Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy) trial.
https://diabetes.acponline.org/archives/2019/06/14/2.htm
14 Jun 2019

Lowering serum urate levels with allopurinol did not improve kidney outcomes in patients with type 1 diabetes

Randomized trial participants with type 1 diabetes and mild-to-moderate diabetic kidney disease who received allopurinol or placebo had similar estimated glomerular filtration rates after three years.
https://diabetes.acponline.org/archives/2020/07/10/1.htm
10 Jul 2020

DPP-4 inhibitors may be effective for some cases of inpatient hyperglycemia

A narrative review considered the available evidence on use of metformin, thiazolidinediones, sulfonylureas, sodium-glucose cotransporter-2 inhibitors, and dipeptidyl peptidase-4 (DPP-4) inhibitors in the hospital.
https://diabetes.acponline.org/archives/2020/06/12/1.htm
12 Jun 2020

Result Page: Prev   8   9   10   11   12   13   14   15   16   17   Next